CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Magnetic resonance imagingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001631
NCT00001631Phase 2Completed
CompareCT.gov

Study of Myocardial Perfusion by MRI

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Nov 4, 1999·Updated Mar 4, 2008

In Brief

A Phase 2 clinical trial evaluating Magnetic resonance imaging for Coronary Disease and 3 related conditions. Completed, across 1 site.

Detailed Summary

Blood flows to areas of the heart providing oxygen and fuel to the pumping muscle. Occasionally the arteries providing the fuel can become blocked. This occurs in coronary artery disease. Magnetic resonance imaging (MRI) can be used to evaluate the blood flow to different areas of the heart muscle. In this study magnetic resonance imaging will be compared to other diagnostic tests (radionucleotide perfusion studies) capable of measuring blood flow to heart muscle.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Disease, Healthy, Hypertrophic Cardiomyopathy, Myocardial Ischemia
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartAug 1, 1997
Study CompletionJan 1, 2003
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

Magnetic resonance imagingprocedure